Evaluation of vancomycin use in a large university-affiliated hospital in eastern France in 1999

Citation
N. Floret et al., Evaluation of vancomycin use in a large university-affiliated hospital in eastern France in 1999, PHARM WORLD, 23(3), 2001, pp. 93-97
Citations number
32
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACY WORLD & SCIENCE
ISSN journal
09281231 → ACNP
Volume
23
Issue
3
Year of publication
2001
Pages
93 - 97
Database
ISI
SICI code
0928-1231(200106)23:3<93:EOVUIA>2.0.ZU;2-5
Abstract
Objective: In 1999, we conducted a retrospective drug utilization review to determine the volume and pattern of vancomycin use in a university-affilia ted hospital in eastern France. Methods: Total vancomycin use was determine d and expressed as vancomycin courses per 100 admitted patients and defined daily doses (DDD) of vancomycin per 100 patient-days. The indication for v ancomycin use was classified as appropriate or inappropriate according to t he guidelines issues by the HICPAC. Results: A total of 311 vancomycin cour ses were given, as 2098 DDD, giving crude incidences of 1.17 courses per 10 0 admitted patients and of 1.19 defined daily doses per 100 patient-days. T he frequency of appropriate courses was 66.7%. Of the 63 inappropriate cour ses of vancomycin, 39.7% and 28.6% were empiric therapy for nosocomial and community-acquired infections, respectively, 20.6% and 6.3% were specific t herapy for nosocomial and community-acquired infections, respectively, and 4.7% were prophylactic. Conclusions: This study shows that vancomycin use i n our hospital resulted in a lower selection pressure than has been reporte d for US university-affiliated hospitals and that comprehensive programs to improve use of vancomycin are needed in our institution.